GlassScriptPhysician profile
Andrew Koerkel
NPI 1932856952
$1,517.62
in general payments reported to CMS, 2019-2025
14 companies · $1,354 in 2025
The $1,354 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $12.83 · 2024: $151 · 2025: $1,354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,517.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $482.41 | 2025 | General - Pain Management, Wavewriter Alpha Prime 16, General - Therapies |
| Saluda Medical Americas, INC. | $163.81 | 2025 | Evoke |
| Abbvie INC. | $153.09 | 2025 | |
| Globus Medical, INC. | $147.85 | 2025 | Senza |
| Bioventus LLC | $144.58 | 2025 | Xcell |
| Madrigal Pharmaceuticals | $121.02 | 2024 | Rezdiffra |
| Medtronic, INC. | $116.89 | 2025 | Synchromedii |
| Spr Therapeutics, INC | $53.08 | 2025 | Sprint Pns System |
| Biotronik Nro, INC. | $37.02 | 2025 | Prospera |
| Exact Sciences Corporation | $26.95 | 2023-2024 | Cologuard Collection Kit |
| Collegium Pharmaceutical, INC. | $21.90 | 2025 | Belbuca |
| Pfizer INC. | $18.98 | 2025 | |
| Genzyme Corporation | $15.63 | 2024 | |
| Avanos Medical | $14.41 | 2025 | Coolief Cooled Radiofrequency |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Koerkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.